Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.386
https://www.valueinhealthjournal.com/article/S1098-3015(15)02462-6/fulltext
Section Title :
Research Podium Presentations - Session 1
Section Order :
2613
First Page :
A843
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02462-6&doi=10.1016/j.jval.2015.09.386